Internal Medicine, Hematology & Oncology · Little Silver, NJ
NPI
1265427223
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
180 White Rd, Suite 101
Little Silver, NJ, 07739
Phone (732) 530-8666
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.6M
186,159 services
Medicare patients, 2024
1,033
Average age 76
Drug cost, 2024
$6.1M
1,681 prescriptions
Company payments, 2025
$308
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Denis B Fitzgerald was code J9271 (injection, pembrolizumab, 1 mg), 24,200 times for 24 patients. In total Denis B Fitzgerald billed 186,159 services in 156 codes, and Medicare paid $4.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 24,200 | 24 | $44.82 | $1.1M |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 22,680 | 13 | $39.17 | $888K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 13,700 | 12 | $0.06 | $761 |
| J0185 Injection, aprepitant, 1 mg | Office | 10,400 | 25 | $1.35 | $14K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,150 | 12 | $0.11 | $698 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 5,900 | 45 | $15.79 | $93K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,811 | 79 | $0.09 | $344 |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 3,696 | 11 | $19.21 | $71K |
| 85025 Blood Count | Office | 2,430 | 861 | $7.59 | $18K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,390 | 16 | $25.04 | $60K |
| 36415 Venipuncture Blood Collection | Office | 2,028 | 828 | $8.63 | $18K |
| J0897 Injection, denosumab, 1 mg | Office | 1,740 | 19 | $20.41 | $36K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,690 | 45 | $0.70 | $1,181 |
| 99214 Office E&M - Established | Office | 1,451 | 507 | $103.83 | $151K |
| 96367 Intravenous Infusion, Hydration | Office | 925 | 108 | $24.14 | $22K |
By year: 2022 $4.9M for 184,523 services; 2023 $4.5M for 169,811 services; 2024 $4.6M for 186,159 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,430 | 861 | $7.59 | $18K |
| 36415 Venipuncture Blood Collection | 2,028 | 828 | $8.63 | $18K |
Medicare prescription drug claims, 2024
In 2024, the drug Denis B Fitzgerald prescribed most often to Medicare patients was Letrozole, with 282 prescriptions and refills. In total Denis B Fitzgerald wrote 1,681 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 282 | 813 | 82 | $7,484 |
| Anastrozole Generic | 78 | 202 | 27 | $1,614 |
| Hydroxyurea Generic | 59 | 142 | 17 | $2,939 |
| Acyclovir Generic | 58 | 132 | 20 | $1,093 |
| Imbruvica Ibrutinib | 53 | 53 | Under 11 | $887K |
| Xarelto Rivaroxaban | 51 | 85 | 12 | $46K |
| Brukinsa Zanubrutinib | 51 | 51 | Under 11 | $758K |
| Tamoxifen Citrate Generic | 48 | 128 | 16 | $1,287 |
| Revlimid Lenalidomide | 44 | 44 | Under 11 | $778K |
| Prednisone Generic | 41 | 80 | 24 | $454 |
| Eliquis Apixaban | 32 | 56 | Under 11 | $31K |
| Xtandi Enzalutamide | 30 | 30 | Under 11 | $417K |
| Oxycodone Hcl Generic | 30 | 30 | Under 11 | $818 |
| Warfarin Sodium Generic | 29 | 75 | Under 11 | $342 |
| Raloxifene Hcl Generic | 26 | 78 | Under 11 | $1,555 |
Brand drugs: - claims; generic drugs: 1,170 claims; opioid claims: 99.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Denis B Fitzgerald $308 ($308 in general payments such as food, travel and fees) from 5 companies. The largest payer was W. L. Gore & Associates, Inc. with $97.26.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.